Current Environment:

Summary

The goal of this study is to conduct a prospective, longitudinal natural history study of children and adults with Angelman Syndrome using investigator-observed and parent-reported outcome measures to obtain data that will be useful for future clinical trials.

Conditions

Angelman Syndrome

Recruitment Status

Recruiting

Detailed Description

The overall goal is to increase our understanding of the long-term natural history of Angelman syndrome and obtain Angelman-specific norms for outcome measures that can be used in clinical trials, ultimately improving the care of individuals with Angelman syndrome.

Eligibility Criteria

Inclusion Criteria:

Molecular diagnosis of Angelman syndrome

Exclusion Criteria:

Presence of another condition, unrelated to Angelman syndrome, that affects neurodevelopment

Gender

All

Min Age

N/A

Max Age

N/A

Download Date

August 16, 2022

Principal Investigator

Wen-Hann Tan

This field has been modified from ClinicalTrials.gov to show a contact specific to Boston Children's.

Primary Contact Information

Lotus Lichty
Lotus.Lichty@childrens.harvard.edu
617-919-2536

This field has been modified from ClinicalTrials.gov to show a contact specific to Boston Children's.

For more information on this trial, visit clinicaltrials.gov.

Contact

For more information and to contact the study team: